News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,402 Results
Type
Article (40921)
Company Profile (267)
Press Release (680204)
Multimedia
Podcasts (80)
Webinars (17)
Section
Business (204674)
Career Advice (2022)
Deals (35534)
Drug Delivery (110)
Drug Development (81380)
Employer Resources (173)
FDA (16410)
Job Trends (14944)
News (346406)
Policy (32736)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2565)
Accelerated approval (31)
Adcomms (24)
Allergies (137)
Alliances (49584)
ALS (167)
Alzheimer's disease (1658)
Antibody-drug conjugate (ADC) (305)
Approvals (16675)
Artificial intelligence (501)
Autoimmune disease (143)
Automation (37)
Bankruptcy (361)
Best Places to Work (11639)
BIOSECURE Act (20)
Biosimilars (187)
Biotechnology (174)
Bladder cancer (157)
Brain cancer (55)
Breast cancer (631)
Cancer (4750)
Cardiovascular disease (396)
Career advice (1707)
Career pathing (35)
CAR-T (275)
CDC (44)
Celiac Disease (2)
Cell therapy (728)
Cervical cancer (36)
Clinical research (69498)
Collaboration (1667)
Company closure (4)
Compensation (1141)
Complete response letters (52)
COVID-19 (2707)
CRISPR (87)
C-suite (810)
Cystic fibrosis (143)
Data (6151)
Decentralized trials (2)
Denatured (25)
Depression (130)
Diabetes (495)
Diagnostics (6669)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (241)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (226)
Earnings (90040)
Editorial (55)
Employer branding (21)
Employer resources (151)
Events (117230)
Executive appointments (958)
FDA (19485)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1445)
Gene editing (191)
Generative AI (42)
Gene therapy (582)
GLP-1 (962)
Government (4653)
Grass and pollen (6)
Guidances (384)
Healthcare (18871)
HIV (55)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (244)
Immuno-oncology (53)
Indications (103)
Infectious disease (2965)
Inflammatory bowel disease (186)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (242)
Interviews (315)
IPO (16639)
IRA (49)
Job creations (3641)
Job search strategy (1427)
JPM (56)
Kidney cancer (15)
Labor market (83)
Layoffs (545)
Leadership (30)
Legal (7955)
Liver cancer (91)
Longevity (14)
Lung cancer (639)
Lymphoma (371)
Machine learning (42)
Management (59)
Manufacturing (776)
MASH (161)
Medical device (13781)
Medtech (13833)
Mergers & acquisitions (19952)
Metabolic disorders (1251)
Multiple sclerosis (156)
NASH (16)
Neurodegenerative disease (307)
Neuropsychiatric disorders (86)
Neuroscience (2865)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4509)
Now hiring (65)
Obesity (587)
Opinion (256)
Ovarian cancer (164)
Pain (195)
Pancreatic cancer (222)
Parkinson's disease (279)
Partnered (33)
Patents (486)
Patient recruitment (471)
Peanut (55)
People (58816)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21669)
Phase 2 (30585)
Phase 3 (22789)
Pipeline (5082)
Policy (278)
Postmarket research (2567)
Preclinical (9193)
Press Release (64)
Prostate cancer (234)
Psychedelics (47)
Radiopharmaceuticals (277)
Rare diseases (814)
Real estate (5954)
Recruiting (69)
Regulatory (24417)
Reports (51)
Research institute (2383)
Resumes & cover letters (351)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (146)
Series A (237)
Series B (184)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3612)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (53)
Vaccines (983)
Venture capital (87)
Weight loss (377)
Women's health (87)
Worklife (18)
Date
Today (20)
Last 7 days (598)
Last 30 days (1959)
Last 365 days (29747)
2026 (2831)
2025 (30177)
2024 (35221)
2023 (40086)
2022 (51178)
2021 (55716)
2020 (54099)
2019 (46543)
2018 (35026)
2017 (32128)
2016 (31495)
2015 (37569)
2014 (31334)
2013 (26375)
2012 (28590)
2011 (29279)
2010 (27377)
Location
Africa (737)
Alabama (83)
Alaska (7)
Arizona (305)
Arkansas (13)
Asia (39214)
Australia (6410)
California (11154)
Canada (3249)
China (1083)
Colorado (471)
Connecticut (469)
Delaware (332)
Europe (84483)
Florida (1662)
Georgia (353)
Hawaii (3)
Idaho (61)
Illinois (851)
India (62)
Indiana (513)
Iowa (22)
Japan (417)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1369)
Massachusetts (7992)
Michigan (319)
Minnesota (625)
Mississippi (5)
Missouri (125)
Montana (31)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2967)
New Mexico (28)
New York (2941)
North Carolina (1436)
North Dakota (8)
Northern California (5435)
Ohio (330)
Oklahoma (21)
Oregon (41)
Pennsylvania (2252)
Puerto Rico (22)
Rhode Island (47)
South America (1108)
South Carolina (65)
South Dakota (1)
Southern California (4340)
Tennessee (172)
Texas (1721)
United States (39555)
Utah (333)
Vermont (1)
Virginia (256)
Washington D.C. (81)
Washington State (914)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
721,402 Results for "transcat inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Transcat to Host Third Quarter Fiscal Year 2026 Conference Call and Webcast on Tuesday, February 3, 2026 at 4:30 p.m. Eastern Time
January 20, 2026
·
4 min read
Press Releases
Transcat to Attend Upcoming Investor Conferences in November 2025
October 29, 2025
·
3 min read
Press Releases
Transcat Reports Strong Fiscal Second Quarter 2026 Financial Results with Double-Digit Revenue & Gross Profit Growth
November 3, 2025
·
19 min read
Press Releases
Transcat to Host Second Quarter Fiscal Year 2026 Conference Call and Webcast on Monday, November 3, 2025 at 4:30 p.m. Eastern Time
October 22, 2025
·
2 min read
Business
Transcat Inc. Announces Executive Leadership Changes - April 09, 2024
Transcat Inc. announced that Mark Doheny will step down as Chief Operating Officer of Transcat effective immediately.
April 9, 2024
·
4 min read
Press Releases
Transcat to Participate in the D.A. Davidson 24th Annual Diversified Industrials & Services Conference on September 18
September 4, 2025
·
2 min read
Deals
Transcat accelerates the growth of its high margin rental business with the acquisition of Axiom Test Equipment, Inc.
Transcat, Inc. announced that it has acquired all of the capital stock of privately-held Axiom Test Equipment, Inc., effective August 8, 2023.
August 8, 2023
·
6 min read
Deals
Transcat Extends Its Professional Services Business With Acquisition of SteriQual, Inc.
Transcat, Inc., a leading provider of accredited calibration services, enterprise asset management services, and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it has purchased all of the capital stock of privately-held SteriQual, Inc., effective July 12, 2023.
July 12, 2023
·
5 min read
Press Releases
Transcat Reports Second Quarter Results with Growth in Revenue and Gross Profit
October 29, 2024
·
18 min read
Business
Transcat Announces First Quarter Fiscal Year 2024 Conference Call and Webcast
Transcat, Inc. announced that it will release its first quarter fiscal year 2024 results after the close of financial markets on Monday, July 31, 2023.
July 17, 2023
·
2 min read
1 of 72,141
Next
